These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8862188)

  • 41. [Action of levorin on the incorporation of labelled amino acids into the proteins of Ehrlich ascitic cancer cells].
    Lishnevskaia EB; Gorozhankina IS
    Antibiotiki; 1983 Apr; 28(4):294-7. PubMed ID: 6859828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative enhancement of hyperthermia lethality on tumor cells by procaine and lanthanum.
    Anghileri LJ; Crone MC; Marchal C; Robert J
    Neoplasma; 1983; 30(5):547-9. PubMed ID: 6656957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of levorin on the activity of facilitated diffusion systems in murine Ehrlich cancer cells].
    Lishnevskaia EB; Gorozhankina IS; Tereshin IM
    Antibiotiki; 1982 Feb; 27(2):141-4. PubMed ID: 7065649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paraquat-induced lipid peroxidation and injury in Ehrlich ascites tumor cells.
    Karakashev P; Petrov L; Alexandrova A
    Neoplasma; 2000; 47(2):122-4. PubMed ID: 10985479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rifampicin and verapamil induce the expression of P-glycoprotein in vivo in Ehrlich ascites tumor cells.
    Granzotto M; Drigo I; Candussio L; Rosati A; Bartoli F; Giraldi T; Decorti G
    Cancer Lett; 2004 Mar; 205(1):107-15. PubMed ID: 15036667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of coumarin heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity against tumour cells.
    Manojkumar P; Ravi TK; Subbuchettiar G
    Acta Pharm; 2009 Jun; 59(2):159-70. PubMed ID: 19564141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lucigenin chemiluminesence. A new approach to study the redox activity of Ehrlich ascetic tumor cells.
    Al-Hashimi AH; Ettinger KV
    Saudi Med J; 2001 Feb; 22(2):164-9. PubMed ID: 11299414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Increase in access to SH-groups of membrane proteins in Ehrlich ascites carcinoma cells upon purinergic receptor activation].
    Rybina VV; Zinchenko VP
    Biofizika; 1997; 42(2):455-8. PubMed ID: 9172691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deoxyribonucleic acid polymerase from Ehrlich ascites-tumour cells and other sources.
    Slater JP
    Biochem J; 1967 Aug; 104(2):30P. PubMed ID: 6048768
    [No Abstract]   [Full Text] [Related]  

  • 50. Factors of Ehrlich Ascites Tumor resistance to oxidative stress.
    Hristov P; Tyurin V; Petrov L
    Acta Physiol Pharmacol Bulg; 1995; 21(3):49-55. PubMed ID: 8868366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Caffeine inhibits the development of Ehrlich ascites carcinoma cells in female mice.
    Mukhopadhyay S; Poddarr MK
    Indian J Exp Biol; 2001 Aug; 39(8):735-41. PubMed ID: 12018573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzymes of creatine biosynthesis, arginine and methionine metabolism in normal and malignant cells.
    Bera S; Wallimann T; Ray S; Ray M
    FEBS J; 2008 Dec; 275(23):5899-909. PubMed ID: 19021765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Titanocene modulation of cytokine imbalance induced by Ehrlich ascites tumour progression.
    Valadares MC; Klein SI; Queiroz ML
    Eur J Pharmacol; 2004 Oct; 503(1-3):203-8. PubMed ID: 15496315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of the flavonoid (+)-catechin on the permeability of Ehrlich mouse ascites tumour cell membranes.
    Ring K; Ehle H; Schwarz M
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):217-24. PubMed ID: 1004633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Action of ribonuclease and desoxyribonuclease on the incorporation of L-glutamic acid U-C-14 and methionine S-35 in tumor cells of Ehrlich's ascites carcinoma].
    Soru E; Banu I; Lăzărescu M; Licurici V
    Stud Cercet Med Interna; 1965; 6(4):413-20. PubMed ID: 5863299
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of Aloe vera leaf pulp extract on Ehrlich ascites tumours in mice.
    Akev N; Turkay G; Can A; Gurel A; Yildiz F; Yardibi H; Ekiz EE; Uzun H
    Eur J Cancer Prev; 2007 Apr; 16(2):151-7. PubMed ID: 17297391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Digitonin permeabilization of Saccharomyces cerevisiae cells for in situ enzyme assay.
    Cordeiro C; Freire AP
    Anal Biochem; 1995 Jul; 229(1):145-8. PubMed ID: 8533887
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT).
    Gumińska M; Ignacak J; Wójcik E
    Pol J Pharmacol; 1996; 48(5):495-501. PubMed ID: 9112691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of levorin on transport of neutral amino acids into cancer cells].
    Lishnevskaia EB; Gorozhankina IS; Tereshin IM
    Antibiotiki; 1982 Mar; 27(3):186-91. PubMed ID: 7092195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.